News
Public · Published
Wells Fargo maintains Merit Medical Systems at Equal-Weight, raises price target to $92 from $83
Wells Fargo kept its Equal-Weight rating on Merit Medical Systems and raised its price target to $92 from $83, a 10.8% increase. The new target implies a downside of 1.5% from the October 29 close of $93.39.
Published:
Updated:
What happened
Wells Fargo kept its Equal-Weight rating on Merit Medical Systems and raised its price target to $92 from $83, a 10.8% increase. The new target implies a downside of 1.5% from the October 29 close of $93.39.
Confirmed
Global impact / market context
A higher price target signals the analyst sees more value in Merit Medical, yet Equal-Weight means holding rather than buying more. Because $92 sits just below the $93.39 close, the analyst sees the share price roughly where it should be, offering little upside.
Analyst inference
Other recent analyst targets run from $90 to $110, so Wells Fargo's $92 is among the lower views. That range shows disagreement about how much Merit Medical is worth, which can leave investors uncertain about whether the current share price is justified.
Analyst inference
What to watch
- Watch whether Merit Medical's share price stays near the $93.39 October 29 close, since Wells Fargo's $92 target implies only a small 1.5% downside from there. Confirmed
- Watch whether other analysts change their ratings or price targets, as the recent range of $90 to $110 could shift if new notes are published. Proposed
- Watch whether the company's future results support the higher target, because analyst target changes often reflect updated expectations for revenue, costs, or profit. Analyst inference
Evidence
- Original source link unavailable